Table 3.
Display of the number of subjects (%) according to qualitative variables and median (min–max) or arithmetic mean ± SD of quantitative variables in relation to the examined groups (control group, groups with moderate and mild form of SARS-CoV-2 infection).
| KERRYPNX | Groups of Subjects with SARS-CoV-2 Infection | |||
|---|---|---|---|---|
| Control Group | Mild Form | Moderate Form | p | |
| Sex | ||||
| Male | 10 (62.5) | 10 (62.5) | 13 (56) | 0.905 † |
| Female | 6 (37.5) | 6 (37.5) | 10 (44) | |
| Age (years) | 37.5 (35–40) | 38 (35–40) | 38 (35–40) | 0.718 * |
| BMI kg/m2 | 21.2 (19.4–25) | 20.9 (19–26) | 24.6 (22–27) | <0.001 |
| Body temperature (°C) | 36.5 (36–37.1) | 36.5 (36–37) | 36.6 (36–37) | 0.791 * |
| RR systolic | 123 ± 8.1 | 124 ± 8.2 | 127 ± 7 | 0.181 †† |
| RR diastolic | 72.4 ± 5.9 | 75 ± 6.1 | 79 ± 6 | 0.003 †† |
| Hgb g/L | 153 (137–165) | 146.3 (125–162) | 152 (134–160) | 0.249 * |
| Hct L/L | 0.525 (0.490–0.590) | 0.497 (0.44–0.57) | 0.50 (0.44–0.56) | 0.007 * |
| Leukocytes × 109/L | 6.5 (4.8–8) | 6.4 (4.9–9) | 6.5 (4–9.2) | 0.956 * |
| Platelets × 109/L | 211 (167–426) | 405 (310–555) | 532 (383–632) | <0.001 * |
| Erythrocytes × 1012/L | 5.2 (4.9–5.9) | 4.9 (4.4–4.7) | 4,7 (4.1–5.5) | <0.001 * |
| Urea mm/L | 4.9 (3.1–7.6) | 5.5 (3.2–7.3) | 5.0 (3.8–7.9) | 0.557 * |
| Creatinine µm/L | 72.5 (54–83) | 65.5 (54–87) | 78 (47–97) | 0.138 * |
| Cholesterol mm/L | 4.8 (4–5) | 4.4 (4–5) | 4.5 (4.1–5.4) | 0.305 * |
| Triglycerides mm/L | 1.3 (1.1–1.7) | 1.5 (1.1–1.7) | 1.6 (1.1–2) | 0.077 * |
* Kruskal–Wallis test; †† ANOVA; † χ2 test. †† There is a statistically significant difference (F = 6.7; p = 0.003) between values of RR days between the examined groups.